logo

NHTC

Natural Health Trends·NASDAQ
--
--(--)
--
--(--)
1.12 / 10
Underperform

NHTC's fundamental status is unfavorable, scoring only 1.1 out of 10. Key weaknesses include negative profitability metrics such as ROA (0%) and annualized net profit margin on assets (0%), both contributing to a depressed valuation. Although the shareholders' equity to total liabilities ratio of 1.6238 offers some balance-sheet cushion, it is insufficient to offset overall profitability concerns. Historical back-tests show consistently negative monthly returns for most fundamental factors, reinforcing the cautionary stance.

Fundamental(1.12)SentimentTechnical

Analysis Checks(2/10)

ROA (%)
Value-0.60
Score1/3
Weight8.34%
1M Return-3.12%
Shareholders’ equity attributable to parent company / Total liabilities (%)
Value1.62
Score3/3
Weight-8.29%
1M Return2.30%
Net cash flow from operating activities / Operating revenue (%)
Value-16.78
Score2/3
Weight3.67%
1M Return-0.95%
Profit-MV
Value0.44
Score1/3
Weight9.75%
1M Return-5.10%
Net profit margin (%)
Value-0.98
Score1/3
Weight8.97%
1M Return-3.03%
Annualized net profit margin on total assets (%)
Value-0.80
Score1/3
Weight8.34%
1M Return-3.12%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score1/3
Weight15.69%
1M Return-4.45%
Net profit / Total operating revenue (%)
Value-0.98
Score1/3
Weight8.97%
1M Return-3.03%
Asset-MV
Value-0.50
Score1/3
Weight26.20%
1M Return-14.28%
Cash-MV
Value0.14
Score1/3
Weight18.37%
1M Return-9.61%
Is NHTC fundamentally strong?
  • NHTC scores 1.12/10 on fundamentals and holds a Premium valuation at present. Backed by its -1.00% ROE, -0.29% net margin, 126.71 P/E ratio, 1.69 P/B ratio, and -116.67% earnings growth, these metrics solidify its Underperform investment rating.